The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the sensitivity of RAS mutation detection of the Idylla platform in comparison to the OncoBEAM RAS CRC assay.
 
Anna Vivancos
Consulting or Advisory Role - Sysmex
Travel, Accommodations, Expenses - Sysmex
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; EA Pharma; EA Pharma; EA Pharma; EA Pharma; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Pfizer; Pfizer; Pfizer; Pfizer; Roche; SERVIER; SERVIER; SERVIER; SERVIER
 
Manuel Benavides
No Relationships to Disclose
 
Elena Elez
No Relationships to Disclose
 
A. Gomez
No Relationships to Disclose
 
Marta Toledano
No Relationships to Disclose
 
Martina Alvarez
No Relationships to Disclose
 
M Rosario Chica Parrado
No Relationships to Disclose
 
Vanesa García-Barberán
No Relationships to Disclose
 
Eduardo Diaz-Rubio
Consulting or Advisory Role - AMGEN; BAYER; GENOMICA; Merck Serono; MSD; Roche
Speakers' Bureau - MSD; SERVIER
Research Funding - AMGEN; AstraZeneca (Inst); Merck Serono (Inst); ROCHE (Inst)